Cutler Group LP Adaptive Biotechnologies Corp Call Options Transaction History

Cutler Group LP

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2022 Aug 04, 2022	SELL	$6.4 - $14.73 $5,760 - $13,257	-900 Reduced 69.23%	400 $0
Q1 2022 Apr 14, 2022	BUY	$10.12 - $28.9 $13,155 - $37,570	1,300 New	1,300 $0
Q4 2020 Jan 21, 2021	SELL	$45.01 - $65.47 $36,008 - $52,376	-800 Closed	0 $0
Q3 2020 Oct 27, 2020	SELL	$35.79 - $48.81 $175,371 - $239,169	-4,900 Reduced 85.96%	800 $4,000
Q2 2020 Jul 22, 2020	BUY	$24.95 - $48.38 $14,970 - $29,028	600 Added 11.76%	5,700 $76,000
Q1 2020 May 07, 2020	BUY	$16.96 - $34.16 $83,104 - $167,383	4,900 Added 2450.0%	5,100 $10,000
Q4 2019 Feb 06, 2020	SELL	$24.56 - $32.8 $49,120 - $65,600	-2,000 Reduced 90.91%	200 $0
Q3 2019 Oct 28, 2019	BUY	$30.31 - $53.51 $66,682 - $117,722	2,200 New	2,200 $0

201

146M

68.8K

42.5K

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $670M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.